Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 421 participants.
Also called NCT04198701
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 421 participants
- Registry
-
NCT04198701
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Belgium, Canada, France, Japan, Netherlands, Spain
- Registry status
- Completed
Technical summary
Registry record NCT04198701. Non-randomized; no masking; primary purpose treatment. Start 2019-12-10 (actual); primary completion 2022-11-28 (actual). Results posted on 2023-12-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
- Acronym
- PULSED AF
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Medtronic PulseSelect Pulsed Field Ablation (PFA) System
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
Record details
- Record id
cardio:ct-nct04198701- Content hash
ac8d1f0e9e7fa35242cb8902e12c0b134c73716c6ca6f31ddd31f0fbed5adbcf